Company Filing History:
2 out of 832,718 Years Active: 2020
Title: Nicole Mohren: Innovator in Equine Metabolic Disorder Treatments
Introduction
Nicole Mohren is a prominent inventor based in Jugenheim, Germany. She has made significant contributions to the field of veterinary medicine, particularly in the treatment of metabolic disorders in equine animals. With a total of 2 patents, her work focuses on innovative solutions to improve the health and well-being of horses.
Latest Patents
Nicole's latest patents include groundbreaking treatments for metabolic disorders in equine animals. The first patent involves a SGLT2 inhibitor or a pharmaceutically acceptable form thereof, aimed at treating and preventing various metabolic disorders such as insulin resistance, hyperinsulinemia, and obesity in horses. The second patent also centers on SGLT2 inhibitors, specifically targeting conditions like laminitis, vascular dysfunction, and Equine Metabolic Syndrome. These inventions represent a significant advancement in equine healthcare.
Career Highlights
Throughout her career, Nicole has demonstrated a commitment to advancing veterinary medicine. Her innovative approaches have garnered attention in the scientific community, and her patents reflect her dedication to improving equine health. Nicole's work is not only beneficial for horses but also contributes to the broader field of veterinary research.
Collaborations
Nicole collaborates with talented individuals in her field, including Dania Birte Reiche and Laura Johnston. These partnerships enhance her research and development efforts, leading to more effective solutions for equine metabolic disorders.
Conclusion
Nicole Mohren is a trailblazer in the field of equine health, with her patents paving the way for new treatments of metabolic disorders. Her innovative work continues to impact the veterinary community positively.